A. Pfleiderer

2.0k total citations
105 papers, 1.5k citations indexed

About

A. Pfleiderer is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, A. Pfleiderer has authored 105 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Reproductive Medicine, 30 papers in Obstetrics and Gynecology and 23 papers in Oncology. Recurrent topics in A. Pfleiderer's work include Ovarian cancer diagnosis and treatment (40 papers), Endometrial and Cervical Cancer Treatments (28 papers) and Cervical Cancer and HPV Research (16 papers). A. Pfleiderer is often cited by papers focused on Ovarian cancer diagnosis and treatment (40 papers), Endometrial and Cervical Cancer Treatments (28 papers) and Cervical Cancer and HPV Research (16 papers). A. Pfleiderer collaborates with scholars based in Germany, United States and Switzerland. A. Pfleiderer's co-authors include W. Kleine, Thomas Bauknecht, Friedrich Kommoss, Willi Sauerbrei, Manuela Kohler, Hans Ikenberg, Paul Bernd Diezel, Andreas du Bois, Michael C. Runge and M Volm and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and American Journal of Obstetrics and Gynecology.

In The Last Decade

A. Pfleiderer

98 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Pfleiderer Germany 23 509 435 424 365 252 105 1.5k
M. Baekelandt Norway 24 664 1.3× 437 1.0× 525 1.2× 426 1.2× 206 0.8× 55 1.4k
Toshio Hirakawa Japan 25 893 1.8× 573 1.3× 339 0.8× 524 1.4× 135 0.5× 55 1.8k
J. J. Kavanagh United States 17 545 1.1× 308 0.7× 396 0.9× 232 0.6× 172 0.7× 50 1.2k
Gianni Amunni Italy 20 449 0.9× 261 0.6× 358 0.8× 526 1.4× 175 0.7× 55 1.2k
Joanne Rutgers United States 23 555 1.1× 381 0.9× 391 0.9× 848 2.3× 193 0.8× 53 1.8k
Toshiko Jobo Japan 20 1.1k 2.1× 294 0.7× 636 1.5× 717 2.0× 141 0.6× 70 1.8k
Cecelia H. Boardman United States 14 351 0.7× 321 0.7× 434 1.0× 531 1.5× 142 0.6× 22 1.2k
K. Swenerton Canada 18 500 1.0× 367 0.8× 455 1.1× 144 0.4× 84 0.3× 31 1.1k
Yasuyuki Hirashima Japan 26 362 0.7× 557 1.3× 542 1.3× 455 1.2× 406 1.6× 81 1.8k
Leah Prentice Canada 18 1.0k 2.0× 909 2.1× 552 1.3× 540 1.5× 456 1.8× 26 2.2k

Countries citing papers authored by A. Pfleiderer

Since Specialization
Citations

This map shows the geographic impact of A. Pfleiderer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Pfleiderer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Pfleiderer more than expected).

Fields of papers citing papers by A. Pfleiderer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Pfleiderer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Pfleiderer. The network helps show where A. Pfleiderer may publish in the future.

Co-authorship network of co-authors of A. Pfleiderer

This figure shows the co-authorship network connecting the top 25 collaborators of A. Pfleiderer. A scholar is included among the top collaborators of A. Pfleiderer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Pfleiderer. A. Pfleiderer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dall, Peter, Armin Hekele, Hans Ikenberg, et al.. (1996). Increasing incidence of CD44v7/8 epitope expression during uterine cervical carcinogenesis. International Journal of Cancer. 69(2). 79–85. 29 indexed citations
2.
Prömpeler, H, H. Madjar, Andreas du Bois, et al.. (1994). Transvaginal sonography of myometrial invasion depth in endometrial cancer. Acta Obstetricia Et Gynecologica Scandinavica. 73(4). 343–346. 21 indexed citations
3.
Kiechle‐Schwarz, M., et al.. (1993). Loss of constitutional heterozygosity on chromosome 11p in human ovarian cancer positive correlation with grade of differentiation. Cancer. 72(8). 2423–2432. 17 indexed citations
4.
5.
Meerpohl, H. G., Willi Sauerbrei, & A. Pfleiderer. (1993). Sequentielle Therapie mit Cisplatin/Cylophosphamid (PC) und Cisplatin/Etoposid (P/VEP) bei fortgeschrittenen Ovarialkarzinomen (OC) mit Resttumor > 2 cm. Archives of Gynecology and Obstetrics. 254(1-4). 915–917. 1 indexed citations
6.
Kiechle‐Schwarz, M., et al.. (1992). Cytogenetic analysis of an adenoid cystic carcinoma of the Bartholin's gland. Cancer Genetics and Cytogenetics. 61(1). 26–30. 9 indexed citations
7.
Kommoss, Friedrich, et al.. (1992). Steroid receptors in ovarian carcinoma: Immunohistochemical determination may lead to new aspects. Gynecologic Oncology. 47(3). 317–322. 54 indexed citations
8.
Kleine, W., et al.. (1990). Prognosis of the adenocarcinoma of the cervix uteri: A comparative study. International Journal of Gynecology & Obstetrics. 32(1). 84–84. 3 indexed citations
9.
Kommoss, Friedrich, S. von Kleist, Manuela Kohler, et al.. (1990). In situ distribution of transforming growth factor α in normal human tissues and in malignant tumours of the ovary. The Journal of Pathology. 162(3). 223–230. 40 indexed citations
10.
Bois, Andreas du, et al.. (1990). Therapierefraktäre Emesis unter Cisplatin. Oncology Research and Treatment. 13(5). 364–368. 3 indexed citations
11.
Runge, Michael C., H. G. Meerpohl, & A. Pfleiderer. (1989). Mitoxantrone Therapy of Advanced Adenocarcinoma of the Endometrium. Oncology Research and Treatment. 12(2). 102–103. 4 indexed citations
12.
Kohler, Manuela, et al.. (1989). Human ovarian carcinomas: correlation of malignancy and survival with the expression of epidermal growth factor receptors (EGF-R) and EGF-like factors (EGF-F). Medical Oncology and Tumor Pharmacotherapy. 6(2). 121–7. 28 indexed citations
13.
Meerpohl, H. G., Johannes Pohl, & A. Pfleiderer. (1986). Phase II study of carboplatinum/cyclophosphamide combination chemotherapy for ovarian cancer. Journal of Cancer Research and Clinical Oncology. 111(S1). S136–S136. 1 indexed citations
14.
Pfleiderer, A.. (1981). Referat Therapie des Ovarialkarzinoms. Archives of Gynecology and Obstetrics. 232(1-4). 200–208. 1 indexed citations
15.
Pfleiderer, A., et al.. (1979). Aktuelle Probleme bei der Nachsorge von Patientinnen mit Karzinomen der Zervix und des Corpus uteri. Oncology Research and Treatment. 2(2). 62–69. 2 indexed citations
16.
Pfleiderer, A., et al.. (1977). Zwei Jahre Erfahrung mit der in vitro-Testung maligner Ovarialtumoren. Archives of Gynecology and Obstetrics. 224(1-4). 358–359. 1 indexed citations
17.
Pfleiderer, A., et al.. (1972). Wirkung von Endoxan auf Ovarialcarcinome in vitro: Eine cytochemische Untersuchung. 212(2). 151–164. 1 indexed citations
18.
Pfleiderer, A., et al.. (1972). Wirkung von Endoxan auf Ovarialcarcinome in vitro. Archives of Gynecology and Obstetrics. 212(2). 151–164. 1 indexed citations
19.
Pfleiderer, A., et al.. (1971). Enzymaktive Stromazellen in Ovarialtumoren. Archives of Gynecology and Obstetrics. 210(2). 150–163. 2 indexed citations
20.
Pfleiderer, A., et al.. (1968). Enzymhistochemische Untersuchungen am Carcinom des Corpus Uteri : eine Studie über Einfluss klinischer und pathologisch-anatomischer Faktoren auf die Enzymverteilung in einem Carcinom. S. Karger eBooks. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Baekelandt Breakdown of academic impact, for papers by Toshio Hirakawa Breakdown of academic impact, for papers by J. J. Kavanagh Breakdown of academic impact, for papers by Gianni Amunni Breakdown of academic impact, for papers by Joanne Rutgers Breakdown of academic impact, for papers by Toshiko Jobo Breakdown of academic impact, for papers by Cecelia H. Boardman Breakdown of academic impact, for papers by K. Swenerton Breakdown of academic impact, for papers by Yasuyuki Hirashima Breakdown of academic impact, for papers by Leah Prentice
Rankless by CCL
2026